Axogen (AXGN) Interest & Investment Income (2010 - 2026)
Axogen (AXGN) posted Interest & Investment Income of $786000.0 for Q2 2026, up 2.34% on a QoQ basis from $768000.0 in Q1 2026, and up 249.33% year-over-year from $225000.0 in Q2 2025.
Powered by 
Analysis
Axogen (AXGN) Interest & Investment Income (2010 - 2026) Analysis & Trends
Axogen has reported Interest & Investment Income for 11 years, with the latest figure at $786000.0 in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 249.33% year-over-year to $786000.0 in Q2 2026; TTM through Jun 2026 was $2.2 million, a 99.02% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 2.37% from the prior year.
- Interest & Investment Income was $786000.0 for Q2 2026 at Axogen, up from $768000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $786000.0 in Q2 2026, with the low at -$46000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $328833.3, with a median of $307500.0 recorded in 2024.
- The largest YoY upside for Interest & Investment Income was 2953.85% in 2022 against a maximum downside of 235.29% in 2022.
- Over 5 years, Interest & Investment Income stood at $397000.0 in 2022, then fell by 15.37% to $336000.0 in 2023, then decreased by 3.27% to $325000.0 in 2024, then advanced by 8.31% to $352000.0 in 2025, then soared by 123.3% to $786000.0 in 2026.
- The last three Interest & Investment Income figures came in at $786000.0 (Q2 2026), $768000.0 (Q1 2026), and $352000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Axogen | 2.51 Bn | 2.40 Bn | 50.67 Mn | 786,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 786,000.00 |
| Mar 31, 2026 | 768,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 272,000.00 |
| Dec 31, 2024 | 325,000.00 |
| Sep 30, 2024 | 296,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 293,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Sep 30, 2023 | 367,000.00 |
| Jun 30, 2023 | 235,000.00 |
| Mar 31, 2023 | 549,000.00 |
| Dec 31, 2022 | 397,000.00 |
| Sep 30, 2022 | 186,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 17,000.00 |